Epilepsy outcome in elderly treated with topiramate: Ergebnisse einer klinischen Pr�fung (original) (raw)

2008

Abstract

Abstract Objectives To explore effectiveness, tolerability and quality of life in elderly patients with epilepsy treated with topiramate. Methods This was a one year, open-label, flexible-dosing clinical trial. Results A total of 107 patients (mean age 69 years, 53% men) were studied during 273±141 days. The average final dose in monotherapy was 98 mg/d vs 153 mg/d in adjunctive treatment.

Andreas Schreiner hasn't uploaded this paper.

Let Andreas know you want this paper to be uploaded.

Ask for this paper to be uploaded.